A citation-based method for searching scientific literature

D M Favara, K McAdam, A Cooke, A Bordessa-Kelly, I Budriunaite, S Bossingham, S Houghton, R Doffinger, N Ainsworth, P G Corrie. Clin Oncol (R Coll Radiol) 2021
Times Cited: 5







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.
Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, Zhian Zhang, Hua You, Meng Wu, Qichao Zheng,[...]. Cancer Discov 2020
775
60

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
Ann-Sofie Rudberg, Sebastian Havervall, Anna Månberg, August Jernbom Falk, Katherina Aguilera, Henry Ng, Lena Gabrielsson, Ann-Christin Salomonsson, Leo Hanke, Ben Murrell,[...]. Nat Commun 2020
161
60

Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Sylvain Ladoire, Vincent Goussot, Emilie Redersdorff, Adele Cueff, Elise Ballot, Caroline Truntzer, Siavoshe Ayati, Leila Bengrine-Lefevre, Nathalie Bremaud, Bruno Coudert,[...]. Eur J Cancer 2021
12
60

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.
Nicola Sweeney, Blair Merrick, Rui Pedro Galão, Suzanne Pickering, Alina Botgros, Harry D Wilson, Adrian W Signell, Gilberto Betancor, Mark Kia Ik Tan, John Ramble,[...]. PLoS One 2021
4
50

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Lennard Y W Lee, Jean-Baptiste Cazier, Thomas Starkey, Sarah E W Briggs, Roland Arnold, Vartika Bisht, Stephen Booth, Naomi A Campton, Vinton W T Cheng, Graham Collins,[...]. Lancet Oncol 2020
274
40

Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection.
Jenny A Doust, Katy J L Bell, Mariska M G Leeflang, Jacqueline Dinnes, Sally J Lord, Sue Mallett, Janneke H H M van de Wijgert, Sverre Sandberg, Khosrow Adeli, Jonathan J Deeks,[...]. BMJ 2021
10
40

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, Karine Le Malicot, Juliette Thariat, Guido Ahle, Cindy Neuzillet, Xavier Paoletti, Olivier Bouché, Kais Aldabbagh,[...]. Eur J Cancer 2020
78
40

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.
Quan-Xin Long, Xiao-Jun Tang, Qiu-Lin Shi, Qin Li, Hai-Jun Deng, Jun Yuan, Jie-Li Hu, Wei Xu, Yong Zhang, Fa-Jin Lv,[...]. Nat Med 2020
40

SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic.
Anna S Berghoff, Margaretha Gansterer, Arne C Bathke, Wolfgang Trutschnig, Philipp Hungerländer, Julia M Berger, Judith Kreminger, Angelika M Starzer, Robert Strassl, Ralf Schmidt,[...]. J Clin Oncol 2020
29
40

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Thomas Nicol, Caroline Lefeuvre, Orianne Serri, Adeline Pivert, Françoise Joubaud, Vincent Dubée, Achille Kouatchet, Alexandra Ducancelle, Françoise Lunel-Fabiani, Hélène Le Guillou-Guillemette. J Clin Virol 2020
129
40

Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study.
Fabrice Carrat, Mathilde Touvier, Gianluca Severi, Laurence Meyer, Florence Jusot, Nathanael Lapidus, Delphine Rahib, Nathalie Lydié, Marie-Aline Charles, Pierre-Yves Ancel,[...]. BMC Infect Dis 2021
17
40

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
Sheila F Lumley, Denise O'Donnell, Nicole E Stoesser, Philippa C Matthews, Alison Howarth, Stephanie B Hatch, Brian D Marsden, Stuart Cox, Tim James, Fiona Warren,[...]. N Engl J Med 2021
469
40

Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation.
Kfir Oved, Liraz Olmer, Yonat Shemer-Avni, Tamar Wolf, Lia Supino-Rosin, George Prajgrod, Yotam Shenhar, Irina Payorsky, Yuval Cohen, Yishai Kohn,[...]. EClinicalMedicine 2020
90
20

Taste and odor abnormalities in cancer patients.
Jae Hee Hong, Pinar Omur-Ozbek, Brian T Stanek, Andrea M Dietrich, Susan E Duncan, Yong Woo Lee, Glenn Lesser. J Support Oncol 2009
110
20

Underdetection of cases of COVID-19 in France threatens epidemic control.
Giulia Pullano, Laura Di Domenico, Chiara E Sabbatini, Eugenio Valdano, Clément Turbelin, Marion Debin, Caroline Guerrisi, Charly Kengne-Kuetche, Cécile Souty, Thomas Hanslik,[...]. Nature 2021
80
20

Smell and taste symptom-based predictive model for COVID-19 diagnosis.
Lauren T Roland, Jose G Gurrola, Patricia A Loftus, Steven W Cheung, Jolie L Chang. Int Forum Allergy Rhinol 2020
70
20

Anosmia and dysgeusia in COVID-19: A systematic review.
Rodrigo M Carrillo-Larco, Carlos Altez-Fernandez. Wellcome Open Res 2020
44
20

Anosmia and loss of smell in the era of covid-19.
Abigail Walker, Gillian Pottinger, Andrew Scott, Claire Hopkins. BMJ 2020
25
20

Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review.
Eva-Maria Gamper, August Zabernigg, Lisa Maria Wintner, Johannes Maria Giesinger, Anne Oberguggenberger, Georg Kemmler, Barbara Sperner-Unterweger, Bernhard Holzner. J Pain Symptom Manage 2012
69
20

Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population.
Behzad Iravani, Artin Arshamian, Aharon Ravia, Eva Mishor, Kobi Snitz, Sagit Shushan, Yehudah Roth, Ofer Perl, Danielle Honigstein, Reut Weissgross,[...]. Chem Senses 2020
36
20

COVID-19 Serological Tests: How Well Do They Actually Perform?
Abdi Ghaffari, Robyn Meurant, Ali Ardakani. Diagnostics (Basel) 2020
66
20


Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.
Long H Nguyen, David A Drew, Mark S Graham, Amit D Joshi, Chuan-Guo Guo, Wenjie Ma, Raaj S Mehta, Erica T Warner, Daniel R Sikavi, Chun-Han Lo,[...]. Lancet Public Health 2020
894
20

Real-time tracking of self-reported symptoms to predict potential COVID-19.
Cristina Menni, Ana M Valdes, Maxim B Freidin, Carole H Sudre, Long H Nguyen, David A Drew, Sajaysurya Ganesh, Thomas Varsavsky, M Jorge Cardoso, Julia S El-Sayed Moustafa,[...]. Nat Med 2020
627
20

Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients.
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat,[...]. JNCI Cancer Spectr 2021
23
20

Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies.
Silke Steinbach, Thomas Hummel, Christina Böhner, Sabina Berktold, Walter Hundt, Monika Kriner, Petra Heinrich, Harald Sommer, Claus Hanusch, Anita Prechtl,[...]. J Clin Oncol 2009
132
20

Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
Suzanne Pickering, Gilberto Betancor, Rui Pedro Galão, Blair Merrick, Adrian W Signell, Harry D Wilson, Mark Tan Kia Ik, Jeffrey Seow, Carl Graham, Sam Acors,[...]. PLoS Pathog 2020
70
20

A systematic review of smell alterations after radiotherapy for head and neck cancer.
M Álvarez-Camacho, S Gonella, S Campbell, R A Scrimger, W V Wismer. Cancer Treat Rev 2017
17
20

Lockdown impact on COVID-19 epidemics in regions across metropolitan France.
Simon Cauchemez, Cécile Tran Kiem, Juliette Paireau, Patrick Rolland, Arnaud Fontanet. Lancet 2020
28
20

Utility of hyposmia and hypogeusia for the diagnosis of COVID-19.
François Bénézit, Paul Le Turnier, Charles Declerck, Cécile Paillé, Matthieu Revest, Vincent Dubée, Pierre Tattevin. Lancet Infect Dis 2020
124
20

Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer.
Jenny McGreevy, Ylva Orrevall, Kerstin Belqaid, Wendy Wismer, Carol Tishelman, Britt-Marie Bernhardson. Support Care Cancer 2014
36
20

The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing.
Kimberly E Hanson, Angela M Caliendo, Cesar A Arias, Mary K Hayden, Janet A Englund, Mark J Lee, Mark Loeb, Robin Patel, Abdallah El Alayli, Osama Altayar,[...]. Clin Infect Dis 2021
63
20

Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
Beth Russell, Charlotte Moss, Anne Rigg, Claire Hopkins, Sophie Papa, Mieke Van Hemelrijck. Ecancermedicalscience 2020
65
20

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Chuanhao Jiang, Yali Wang, Min Hu, Lingjun Wen, Chuan Wen, Yang Wang, Weihong Zhu, Shi Tai, Zhongbiao Jiang, Kui Xiao,[...]. Clin Transl Immunology 2020
40
20

Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Emelie Marklund, Susannah Leach, Hannes Axelsson, Kristina Nyström, Heléne Norder, Mats Bemark, Davide Angeletti, Anna Lundgren, Staffan Nilsson, Lars-Magnus Andersson,[...]. PLoS One 2020
99
20

Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.
Cheryl Yi-Pin Lee, Raymond T P Lin, Laurent Renia, Lisa F P Ng. Front Immunol 2020
149
20


Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta-analysis.
Daniel Mekonnen, Hylemariam Mihiretie Mengist, Awoke Derbie, Endalkachew Nibret, Abaineh Munshea, Hongliang He, Bofeng Li, Tengchuan Jin. Rev Med Virol 2021
33
20

COVID-19 and Cancer: Current Challenges and Perspectives.
Ziad Bakouny, Jessica E Hawley, Toni K Choueiri, Solange Peters, Brian I Rini, Jeremy L Warner, Corrie A Painter. Cancer Cell 2020
100
20

Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort.
Laurence Albiges, Stéphanie Foulon, Arnaud Bayle, Bertrand Gachot, Fanny Pommeret, Christophe Willekens, Annabelle Stoclin, Mansouria Merad, Frank Griscelli, Ludovic Lacroix,[...]. Nat Cancer 2020
50
20

Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the Pandemic.
Marjolein F Q Kluytmans-van den Bergh, Anton G M Buiting, Suzan D Pas, Robbert G Bentvelsen, Wouter van den Bijllaardt, Anne J G van Oudheusden, Miranda M L van Rijen, Jaco J Verweij, Marion P G Koopmans, Jan A J W Kluytmans. JAMA Netw Open 2020
161
20

Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness.
Denis Pierron, Veronica Pereda-Loth, Marylou Mantel, Maëlle Moranges, Emmanuelle Bignon, Omar Alva, Julie Kabous, Margit Heiske, Jody Pacalon, Renaud David,[...]. Nat Commun 2020
39
20

Taste and smell perception and quality of life during and after systemic therapy for breast cancer.
Y C de Vries, S Boesveldt, C S Kelfkens, E E Posthuma, M M G A van den Berg, J Th C M de Kruif, A Haringhuizen, D W Sommeijer, N Buist, S Grosfeld,[...]. Breast Cancer Res Treat 2018
24
20

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.
Mayara Lisboa Bastos, Gamuchirai Tavaziva, Syed Kunal Abidi, Jonathon R Campbell, Louis-Patrick Haraoui, James C Johnston, Zhiyi Lan, Stephanie Law, Emily MacLean, Anete Trajman,[...]. BMJ 2020
440
20

How to interpret and use COVID-19 serology and immunology tests.
David S Y Ong, Paraskevi C Fragkou, Valentijn A Schweitzer, Roy F Chemaly, Charalampos D Moschopoulos, Chrysanthi Skevaki. Clin Microbiol Infect 2021
28
20

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
Jerome R Lechien, Carlos M Chiesa-Estomba, Daniele R De Siati, Mihaela Horoi, Serge D Le Bon, Alexandra Rodriguez, Didier Dequanter, Serge Blecic, Fahd El Afia, Lea Distinguin,[...]. Eur Arch Otorhinolaryngol 2020
20

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
Lennard Yw Lee, Jean-Baptiste Cazier, Vasileios Angelis, Roland Arnold, Vartika Bisht, Naomi A Campton, Julia Chackathayil, Vinton Wt Cheng, Helen M Curley, Matthew W Fittall,[...]. Lancet 2020
600
20

Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.
Leo C James, Anthony H Keeble, Zahra Khan, David A Rhodes, John Trowsdale. Proc Natl Acad Sci U S A 2007
243
20

Altered sirtuin expression is associated with node-positive breast cancer.
N Ashraf, S Zino, A Macintyre, D Kingsmore, A P Payne, W D George, P G Shiels. Br J Cancer 2006
178
20

Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (γ-glutamic acid) nanoparticles.
Yohei Mukai, Tomoyo Yoshinaga, Mai Yoshikawa, Kazuhiko Matsuo, Tomoaki Yoshikawa, Keisuke Matsuo, Kazuyuki Niki, Yasuo Yoshioka, Naoki Okada, Shinsaku Nakagawa. J Immunol 2011
29
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.